Treatment heterogeneity in asthma: genetics of response to leukotriene modifiers.
作者： John J. Lima
DOI: 10.1007/BF03256228
关键词:
摘要: … In human mast cells, basophils, eosinophils, and macrophages, LTA 4 is converted to LTB 4 by LTA 4 hydrolase (LTA4H) or conjugated with reduced glutathione by LTC 4 synthase (…
springer.com
sci-hub.se 参考文章(68)
I Leier, G Jedlitschky, U Buchholz, S P Cole, R G Deeley, D Keppler, The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. Journal of Biological Chemistry. ,vol. 269, pp. 27807- 27810 ,(1994) , 10.1016/S0021-9258(18)46856-1
Graeme P. Currie, John J. Lima, Jim E. Sylvester, Daniel K. C. Lee, Wendy J. R. Cockburn, Brian J Lipworth, Leukotriene C4 synthase polymorphisms and responsiveness to leukotriene antagonists in asthma British Journal of Clinical Pharmacology. ,vol. 56, pp. 422- 426 ,(2003) , 10.1046/J.1365-2125.2003.01952.X
Jeffrey M. Drazen, Chandri N. Yandava, Louise Dubé, Natalie Szczerback, Richard Hippensteel, Antonino Pillari, Elliot Israel, Nicholas Schork, Eric S. Silverman, David A. Katz, Jeffrey Drajesk, Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment Nature Genetics. ,vol. 22, pp. 168- 170 ,(1999) , 10.1038/9680
Haiyung Cheng, Jonathan A. Leff, Raju Amin, Barry J. Gertz, Marina De Smet, Nancy Noonan, J. Douglas Rogers, William Malbecq, Dale Meisner, G. Somers, Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females Pharmaceutical Research. ,vol. 13, pp. 445- 448 ,(1996) , 10.1023/A:1016056912698
J. I. Isenberg, G. A. Doss, M. A. Koss, S. K. Balani, V. Pratha, C. Dufresne, J. H. Lin, A. Freeman, K. C. Lasseter, R. R. Miller, J. D. Rogers, M. Chiba, S. D. Holland, J. I. Schwartz, R. D. Amin, B. H. Arison, B. J. Gertz, X. Xu, T. A. Baillie, Metabolic profiles of montelukast sodium (singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile Drug Metabolism and Disposition. ,vol. 25, pp. 1282- 1287 ,(1997)
Francine M Ducharme, Toby J Lasserson, Christopher J Cates, Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Cochrane Database of Systematic Reviews. ,(2006) , 10.1002/14651858.CD003137.PUB3
K H In, K Asano, D Beier, J Grobholz, P W Finn, E K Silverman, E S Silverman, T Collins, A R Fischer, T P Keith, K Serino, S W Kim, G T De Sanctis, C Yandava, A Pillari, P Rubin, J Kemp, E Israel, W Busse, D Ledford, J J Murray, A Segal, D Tinkleman, J M Drazen, Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. Journal of Clinical Investigation. ,vol. 99, pp. 1130- 1137 ,(1997) , 10.1172/JCI119241
Kerstin Malmstrom, Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma Annals of Internal Medicine. ,vol. 130, pp. 487- 495 ,(1999) , 10.7326/0003-4819-130-6-199903160-00005
Bruno Hagenbuch, Peter J. Meier, Organic anion transporting polypeptides of the OATP/ SLC21 family : phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties Pflügers Archiv: European Journal of Physiology. ,vol. 447, pp. 653- 665 ,(2004) , 10.1007/S00424-003-1168-Y
Richard B. Kim, Transporters and drug discovery: why, when, and how. Molecular Pharmaceutics. ,vol. 3, pp. 26- 32 ,(2006) , 10.1021/MP050084O